Subscribe To Our Free Newsletter |
Zydus Life gains after receiving USFDA nod for Chlorpromazine Hydrochloride Injection
Zydus Lifesciences added 2.36% to Rs 991.55 after the company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Chlorpromazine Hydrochloride Injection.